From: Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly
a) Participants’ demographics by brain amyloid PET result | |||||||
J-TRC | BioFINDER | ||||||
Aβ-PET negative | Aβ-PET positive | p-value | Aβ-PET negative | Aβ-PET positive | p-value | ||
N, (%) | 393(83) | 81(17) | 108(61) | 69(39) | |||
PET tracer; FBP/FMM, (%) | 180(46)/213(54) | 22(27)/59(73) | 0/108 | 0/69 | |||
Age (mean ± SD, years) | 71.2 ± 6.5 | 73.5 ± 6.3 | 0.0015 | 71.5 ± 5.9 | 73.5 ± 4.9 | 0.023 | |
Male/Female, (%) | 224(57)/169(43) | 44(54)/37(46) | N.S | 49(45)/59(55) | 34(49)/35(51) | N.S | |
Education (mean ± SD, years) | 14.4 ± 2.4 | 14.1 ± 2.8 | N.S | 11.9 ± 3.5 | 11.0 ± 3.0 | N.S | |
APOE ε4 +/- , (%) | 61(16)/332(84) | 35(43)/46(57) | < 0.001 | 22(21)/84(79) | 50(72)/19(28) | < 0.001 | |
CDR 0/CDR 0.5 (J-TRC), (%) CU/MCI (BioFINDER), (%) | 289(74)/104(26) | 42(52)/39(48) | < 0.001 | 83(77)/25(23) | 31(45)/38(55) | < 0.001 | |
MMSE (mean ± SD) | 28.2 ± 1.9 | 27.4 ± 2.6 | 0.029 | 28.4 ± 1.6 | 27.6 ± 1.7 | 0.001 | |
WMS Logical Memory IIa; Delayed Recall (mean ± SD) | 8.6 ± 4.2 | 6.2 ± 4.9 | < 0.001 | N.A | N.A | ||
WAIS-R; Digit Symbol Substitution Test (mean ± SD) | 49.6 ± 12.2 | 43.9 ± 11.2 | < 0.001 | N.A | N.A | ||
FCSRT (mean ± SD) | 46.7 ± 3.2 | 43.7 ± 6.9 | < 0.001 | N.A | N.A | ||
CFI (mean ± SD) | Self | 3.4 ± 2.4 | 4.7 ± 3.0 | < 0.001 | N.A | N.A | |
Study partner | 1.6 ± 1.7 | 2.7 ± 2.6 | < 0.001 | N.A | N.A | ||
Plasma Aβ42/40 (mean ± SD) | 0.043 ± 0.009 | 0.034 ± 0.006 | < 0.001 | 0.053 ± 0.006 | 0.046 ± 0.004 | < 0.001 | |
Plasma p-tau217 (mean ± SD, pg/ml) | 0.16 ± 0.08 | 0.33 ± 0.17 | < 0.001 | 0.17 ± 0.06 | 0.32 ± 0.14 | < 0.001 | |
PET Centiloid Scale (mean ± SD) | -0.19 ± 11.46 | 52.02 ± 31.14 | < 0.001 | N.A | N.A | ||
b) Participants’ demographics by cognitive assessment | |||||||
J-TRC | BioFINDER | ||||||
CDR 0 | CDR 0.5 | p-value | CU | MCI | p-value | ||
N, (%) | 331(70) | 143(30) | 114(64) | 63(36) | |||
Age (mean ± SD, years) | 70.7 ± 6.4 | 73.8 ± 6.3 | < 0.001 | 72.9 ± 5.4 | 71.1 ± 5.8 | 0.036 | |
Male/Female, (%) | 191(58)/140(42) | 77(54)/66(46) | N.S | 43(38)/71(62) | 40(63)/23(37) | 0.001 | |
Education (mean ± SD, years) | 14.5 ± 2.5 | 13.8 ± 2.5 | 0.0075 | 12.1 ± 3.2 | 10.6 ± 3.4 | 0.004 | |
APOE ε4 +/- , (%) | 59(18)/272(82) | 37(26)/106(74) | N.S | 42(38)/70(64) | 30(48)/33(52) | N.S | |
Aβ-PET -/+ , (%) | 289(87)/42(13) | 104(73)/39(27) | < 0.001 | 83(73)/31(27) | 25(40)/38(60) | < 0.001 | |
MMSE (mean ± SD) | 28.5 ± 1.7 | 27 ± 2.4 | < 0.001 | 28.7 ± 1.3 | 27.0 ± 1.7 | < 0.001 | |
WMS Logical Memory IIa; Delayed Recall (mean ± SD) | 9.2 ± 4.1 | 5.8 ± 4.3 | < 0.001 | N.A | N.A | ||
WAIS-R; Digit Symbol Substitution Test (mean ± SD) | 50.8 ± 11.8 | 43.7 ± 11.8 | < 0.001 | N.A | N.A | ||
FCSRT (mean ± SD) | 47.1 ± 1.5 | 44.1 ± 7.0 | < 0.001 | N.A | N.A | ||
CFI (mean ± SD) | Self | 3.1 ± 2.2 | 4.8 ± 2.9 | < 0.001 | N.A | N.A | |
Study partner | 1.3 ± 1.4 | 2.8 ± 2.4 | < 0.001 | N.A | N.A | ||
Plasma Aβ42/40 (mean ± SD) | 0.043 ± 0.009 | 0.041 ± 0.012 | 0.0023 | 0.051 ± 0.006 | 0.048 ± 0.005 | < 0.001 | |
Plasma p-tau217 (mean ± SD, pg/ml) | 0.17 ± 0.08 | 0.24 ± 0.18 | < 0.001 | 0.20 ± 0.09 | 0.28 ± 0.15 | < 0.001 |